20.12.2017 13:00:00

Syncordia Technologies and Healthcare Solutions, Corp. Announces an Initial Agreement to General Deal Terms for a Debt Refinancing

TORONTO, Dec. 20, 2017 /CNW/ - Syncordia Technologies and Healthcare Solutions, Corp. (TSXV: SYN) ("Syncordia") is pleased to provide an update that it has agreed in principal to the basic deal terms for a refinancing of its existing debt. Under this refinancing plan the existing debt holders would be paid in full in exchange for new debt with a 4-year term. Completion of the new debt structure will be subject to customary approvals including lender approval, diligence, final documentation and TSX Venture approval, but represents a significant milestone in Syncordia's growth plans as a software, information technology diversified healthcare company.

About Syncordia Technologies and Healthcare Solutions, Corp.
We are a software and information technology services company with a focus on healthcare, and with an initial focus on technology enhanced revenue cycle management medical claim processing for healthcare practitioners. We are focused on using our proprietary software suite as an accelerator for growth. Our growth strategy is to acquire healthcare oriented software and information technology service companies and improve their profitability by increasing revenues and improving operating efficiencies with the local management teams. Syncordia will leverage proprietary software to manage scale, drive better customer experiences and enhance margins while driving a competitive sustainable profile.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Certain statements herein may be "forward looking" statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Syncordia or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward-looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and we assume no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances.

SOURCE Syncordia Technologies and Healthcare Solutions, Corp.

Nachrichten zu Synthetic Biologics Inc.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Synthetic Biologics Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!